Jian Ming Mei
Fortuna: 64 M $ al 31/10/2026
Fortuna: 64 M $ al 31/10/2026
Jian Ming Mei is the founder of Antengene Corp.
Ltd., founded in 2018, serving as Chairman & Chief Executive Officer since its founding.
Current jobs include Member at the American Society of Hematology since 2006.
Former jobs include Executive Director-Clinical Development Department at Celgene Corp.
from 2008 to 2017, Senior Director at Novartis Oncology, Inc. from 2006 to 2008, Associate Director at Johnson & Johnson Pharmaceutical Research & Development LLC from 2001 to 2006, Director at Jiangsu Asieris Pharmaceuticals Co. Ltd. from 2014 to 2020, and Member at the American Society of Clinical Oncology, Inc. Education history includes a doctorate from the University of Maryland conferred in 1994 and a doctorate from Xiangya Hospital Central South University conferred in 1989.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/09/2026 | 178.626.994 ( 25,91 % ) | 64 M $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director Ejecutivo | 28/08/2018 |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | 01/01/2006 |
| Empresas | Cargo | Fin |
|---|---|---|
Jiangsu Asieris Pharmaceuticals Co. Ltd. | Director/Miembro de la Junta | 01/12/2020 |
| CELGENE | Director Técnico/Científico/I+D | 01/03/2017 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Director/Miembro de la Junta | 01/10/2008 |
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Corporate Officer/Principal | 01/04/2006 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Commercial Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Xiangya Hospital Central South University
Xiangya Hospital Central South University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antengene Corp. Ltd.
Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
Jiangsu Asieris Pharmaceuticals Co. Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.